His primary areas of study are Heart failure, Internal medicine, Cardiology, Heart disease and Ejection fraction. His Heart failure study combines topics in areas such as Randomized controlled trial, Hazard ratio, Confidence interval, Intensive care medicine and Placebo. His Internal medicine study deals with Surgery intersecting with Renal function and Relative risk.
Christopher M. O'Connor combines subjects such as Clinical endpoint and Blood pressure with his study of Cardiology. His studies deal with areas such as Clinical trial, Randomization, Mortality rate, Emergency medicine and Survival analysis as well as Heart disease. His Ejection fraction research integrates issues from Cardiomyopathy and Depression.
Christopher M. O'Connor mainly investigates Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction. His Heart failure research is multidisciplinary, incorporating elements of Clinical trial, Randomized controlled trial, Heart disease and Hazard ratio. His studies in Internal medicine integrate themes in fields like Placebo and Surgery.
His work carried out in the field of Cardiology brings together such families of science as Blood pressure and Renal function. His Intensive care medicine study incorporates themes from Diuretic, MEDLINE and Emergency medicine. His Ejection fraction research includes elements of Natriuretic peptide and Physical therapy.
Christopher M. O'Connor mostly deals with Heart failure, Internal medicine, Cardiology, Ejection fraction and Clinical trial. His study in Heart failure is interdisciplinary in nature, drawing from both Placebo, Randomized controlled trial, Confidence interval and Intensive care medicine. His Intensive care medicine study combines topics from a wide range of disciplines, such as MEDLINE and Quality of life.
His Hazard ratio, Nesiritide, Renal function and Proportional hazards model study, which is part of a larger body of work in Internal medicine, is frequently linked to Rolofylline, bridging the gap between disciplines. His is doing research in Natriuretic peptide, Acute decompensated heart failure, Myocardial infarction, Coronary artery disease and Cardiogenic shock, both of which are found in Cardiology. His Ejection fraction research includes themes of Blood pressure, Clinical endpoint, Quality of life and Physical therapy.
His main research concerns Heart failure, Internal medicine, Cardiology, Ejection fraction and Hazard ratio. His Heart failure study integrates concerns from other disciplines, such as Clinical trial, Quality of life, Randomized controlled trial, Confidence interval and Intensive care medicine. Within one scientific family, Christopher M. O'Connor focuses on topics pertaining to Placebo under Internal medicine, and may sometimes address concerns connected to Pulmonary hypertension.
His work deals with themes such as Biomarker and Diuretic, which intersect with Cardiology. Christopher M. O'Connor has researched Ejection fraction in several fields, including Physical therapy, Proportional hazards model, Clinical endpoint and Heart rate. His Hazard ratio research incorporates elements of Implantable cardioverter-defibrillator and Brain natriuretic peptide.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.
Paul A. Gurbel;Kevin P. Bliden;Bonnie L. Hiatt;Christopher M. O’Connor.
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
Christopher M. O'Connor;David J. Whellan;David J. Whellan;Kerry L. Lee;Steven J. Keteyian.
Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
Alexander H. Glassman;Christopher M. O'Connor;Robert M. Califf;Karl Swedberg.
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
Milton Packer;Christopher M. O'Connor;Jalal K. Ghali;Milton L. Pressler.
The New England Journal of Medicine (1996)
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker;Kerry L. Lee;David A. Bull;Margaret M. Redfield.
The New England Journal of Medicine (2011)
Mood disorders in the medically ill: scientific review and recommendations.
Dwight L. Evans;Dennis S. Charney;Dennis S. Charney;Lydia Lewis;Robert N. Golden.
Biological Psychiatry (2005)
Effect of nesiritide in patients with acute decompensated heart failure.
C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong.
The New England Journal of Medicine (2011)
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Gregg C. Fonarow;Wendy Gattis Stough;William T. Abraham;Nancy M. Albert.
Journal of the American College of Cardiology (2007)
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Michael S. Cuffe;Robert M. Califf;Kirkwood F. Adams;Raymond Benza.
Relationship of Depression to Increased Risk of Mortality and Rehospitalization in Patients With Congestive Heart Failure
Wei Jiang;Jude Alexander;Eric Christopher;Maragatha Kuchibhatla.
JAMA Internal Medicine (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: